摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7α-hydroxy-5β-androstane-3,17-dione | 91378-51-7

中文名称
——
中文别名
——
英文名称
7α-hydroxy-5β-androstane-3,17-dione
英文别名
(5R,7R,8R,9S,10S,13S,14S)-7-hydroxy-10,13-dimethyl-2,4,5,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-dione
7α-hydroxy-5β-androstane-3,17-dione化学式
CAS
91378-51-7
化学式
C19H28O3
mdl
——
分子量
304.43
InChiKey
WEDQOCWDNTUDQH-UZSWPKKGSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    453.4±45.0 °C(Predicted)
  • 密度:
    1.152±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    22
  • 可旋转键数:
    0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.89
  • 拓扑面积:
    54.4
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • The Design and Synthesis of New Steroidal Compounds as Potential Mimics of Taxoids
    作者:Fanny Roussi、Quoc Anh Ngo、Sylviane Thoret、Françoise Guéritte、Daniel Guénard
    DOI:10.1002/ejoc.200500203
    日期:2005.9
    Eight new steroidal compounds bearing the phenylisoserine and benzoate side-chains of docetaxel were synthesised as potential mimics of antitumour taxoids. They were readily obtained either from cholic acid or from 4-androstene-3,17-dione by a reductive Tsuji–Trost/reduction one-pot reaction. Two compounds showed an unexpected inhibitory activity of tubulin assembly. (© Wiley-VCH Verlag GmbH & Co.
    合成了八种带有多西紫杉醇基异丝氨酸苯甲酸侧链的新甾体化合物,作为抗肿瘤紫杉类的潜在模拟物。它们很容易从胆酸或 4-androstene-3,17-dione 中通过还原性 Tsuji-Trost/还原一锅反应获得。两种化合物显示出意想不到的微管蛋白组装抑制活性。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2005)
  • [EN] METHODS FOR PREPARING BILE ACIDS<br/>[FR] PROCÉDÉS DE PRÉPARATION D'ACIDES BILIAIRES
    申请人:MEDYTOX INC
    公开号:WO2019024920A1
    公开(公告)日:2019-02-07
    The present disclosure provides methods of preparing cholic acid, deoxycholic acid, or chenodeoxycholic acid, an ester thereof, or a pharmaceutically or cosmetically acceptable salt thereof, and novel and useful synthetic intermediates, for example, as described for methods 1, 1A, 1B, 2, 3, 3A, and 4. The method can start with a plant derived steroid as a starting material, such as dehydroepiandrosterone (DHEA) or Acetyl-dehydroepiandrosterone (Ac-DHEA). Also provided are pharmaceutical or cosmetic compositions and uses thereof, which comprise one or more of cholic acid, deoxycholic acid, or chenodeoxycholic acid, an ester thereof, or a pharmaceutically or cosmetically acceptable salt thereof, which is of high purity, for example, free of animal derived impurities.
    本公开提供了制备胆酸去氧胆酸去氧胆酸、其或药用或化妆品可接受的盐的方法,以及新颖且有用的合成中间体,例如,如方法1、1A、1B、2、3、3A和4所述。该方法可以以植物源类固醇作为起始物质开始,例如表雄酮DHEA)或乙酰表雄酮(Ac-DHEA)。还提供了包含胆酸去氧胆酸去氧胆酸、其或药用或化妆品可接受的盐中的一种或多种的药用或化妆品组合物和用途,其具有高纯度,例如,不含动物来源杂质
  • Stereoselective Introduction of Steroid Side Chains. Synthesis of Chenodeoxycholic Acid
    作者:Peter M. Wovkulich、Andrew D. Batcho、Milan R. Uskokovi?
    DOI:10.1002/hlca.19840670229
    日期:1984.3.14
    A new short route to chenodeoxycholic acid has been developed. The synthesis is based on the stereoselective introduction of the steroidal side chain via an ene reaction of methyl acrylate and a (17Z)-ethylidene steroid prepared from androstenedione.
    已经开发了一种新的去鹅去氧胆酸的短途径。合成是基于通过丙烯酸和由雄烯二酮制备的(17Z)-亚乙基类固醇类反应,甾类侧链的立体选择性引入。
  • Methods for preparing bile acids
    申请人:MEDYTOX INC.
    公开号:US11161872B2
    公开(公告)日:2021-11-02
    The present disclosure provides methods of preparing cholic acid, deoxycholic acid, or chenodeoxycholic acid, an ester thereof, or a pharmaceutically or cosmetically acceptable salt thereof, and novel and useful synthetic intermediates, for example, as described for methods 1, 1A, 1B, 2, 3, 3A, and 4. The method can start with a plant derived steroid as a starting material, such as dehydroepiandrosterone (DHEA) or Acetyl-dehydroepiandrosterone (Ac-DHEA). Also provided are pharmaceutical or cosmetic compositions and uses thereof, which comprise one or more of cholic acid, deoxycholic acid, or chenodeoxycholic acid, an ester thereof, or a pharmaceutically or cosmetically acceptable salt thereof, which is of high purity, for example, free of animal derived impurities.
    本公开提供了制备胆酸胆酸去氧胆酸、其或其药学上或化妆品上可接受的盐以及新颖有用的合成中间体的方法,例如,如方法 1、1A、1B、2、3、3A 和 4 所述。该方法可以从植物提取的类固醇作为起始原料,例如表雄酮 (DHEA) 或乙酰基表雄酮 (Ac-DHEA)。此外,还提供了药物或化妆品组合物及其用途,其中包含一种或多种胆酸胆酸去氧胆酸、其或其药学或化妆品上可接受的盐,纯度高,例如不含动物衍生杂质
  • Use of androstane derivatives for enhancing physical performance
    申请人:Marchewitz Eric
    公开号:US20060234993A1
    公开(公告)日:2006-10-19
    A method of decreasing body weight, reducing adipose tissue and reducing appetite in humans comprises administering a 5-Beta androstane derivative or a physiologically acceptable salt, ester or ether thereof of the general formula: wherein R3 is one of α-OH , β-OH, a mixture of α-OH and , β-OH, and O; and R7 is one of α-OH, β-OH and O.
    一种降低人体体重、减少脂肪组织和降低食欲的方法包括施用通式为 5-β-雄甾烷生物或其生理上可接受的盐、或醚: 其中R3是α-OH、β-OH、α-OH和、β-OH的混合物和O中的一种;R7是α-OH、β-OH和O中的一种。
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B